While they are rich in nutrients and are a staple of traditional diets during the colder months, eating too much can have ...

If this is the case, you might be dealing with house allergies. Millions of people suffer from symptoms caused by indoor ...

This cluster of symptoms, sometimes referred to as “Christmas tree syndrome,” typically doesn’t stem from an allergy to the Christmas tree itself. But sometimes certain hitchhikers on the ...

Shares of Figs (NYSE: FIGS) jumped this week after the company reportedly received a buyout offer for around $1 billion. In this video, Travis Hoium shows why private equity buyers may be ...

FIGS, Inc. faces stagnating sales and plummeting earnings, with recent Q3/2024 revenues shrinking by 1.5% YoY and operating losses mounting. Private equity firm Story3 Capital Partners is rumored ...

Doctors prescribe EpiPen (epinephrine injection) to treat anaphylaxis from any cause, including food and medication allergies. Use EpiPen as soon as symptoms start or just after exposure to a ...

Shares of healthcare apparel company Figs (NYSE:FIGS) jumped 17.7% in the morning session after The Wall Street Journal reported that private equity firm, Story3 Capital made an offer to acquire ...

Investing.com -- Story3 Capital Partners (WA:CPAP) has proposed taking Figs Inc (NYSE:FIGS) private, a spokesperson for the private equity firm told Reuters on Tuesday, highlighting concerns ...

A Willy Wonka-esque ‘Figs in Blankets’ plant-based chocolate bar combining sweet figs with a salty vegan bacon seasoning and oat milk chocolate has been created just in time for Christmas.

Story3 offered $6 a share for the common shares outstanding of Figs that it doesn’t already own, according to the letter. Story3 and affiliated funds own a little over 1% of the company’s ...

Figs (FIGS) has received an acquisition bid from private equity firm Story3 Capital Partners that values the medical-apparel maker at over $1B, the Wall Street Journal’s Lauren Thomas reports ...